Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide Mode of Action in Healthy Volunteers Using MRI
NCT07569419Phase 1Recruiting
- Sponsor
- University of Nottingham
- Start
- Mar 2026
- Primary completion
- Aug 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised trial in cystic fibrosis (CF) comparing Linaclotide with Placebo (2 arms). Primary endpoint: Small bowel water content at 360 minutes. Started Mar 2026; status: recruiting.
02
Drugs
linaclotide
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT07569419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07569419.